Peters S, Paz-Ares LG, Reck M, Carbone DP, et al. Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab-Based Treatment in Patients With Metastatic Non-Small Cell Lung Cancer and Tumor PD-L1 <1%: a Pooled Analysis. J Thorac Oncol 2024 Oct 4:S1556-0864(24)02355.
PMID: 39369790